Antiparasitics
PDL Status Values
Y = preferred
N = non-preferred. Non-preferred drugs listed as N but without clinical drug use criteria are subject to the
Non-Preferred Drugs in Select PDL Classes prior authorization criteria.
New drugs will be listed as N until reviewed by the P&T Committee and are subject to the
New Drug Policy.
V = voluntary non-preferred. Non-preferred mental health drugs are listed as V and prior authorization is not required.
Null (i.e. blank) = indicates the class or specific drug has not been reviewed for PDL placement.
To request a Prior Authorization, please use this form.
| Generic Name | Brand Name | Form | PDL Status |
Current Drug Use Criteria | Carveout ‐ Bill FFS |
New Drug Evaluation & Updates |
|---|---|---|---|---|---|---|
| atovaquone | MEPRON | ORAL SUSP | N | |||
| atovaquone | ATOVAQUONE | ORAL SUSP | N | |||
| benznidazole | BENZNIDAZOLE | TABLET | N | |||
| ivermectin | IVERMECTIN | TABLET | N | |||
| mebendazole | EMVERM | TAB CHEW | N | |||
| pentamidine isethionate | PENTAMIDINE ISETHIONATE | VIAL | N | |||
| pentamidine isethionate | NEBUPENT | VIAL-NEB | N | |||
| praziquantel | PRAZIQUANTEL | TABLET | N | |||
| triclabendazole | EGATEN | TABLET | N |